TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H

Bibliographic Details
Main Authors:	Watts, R, Isaacs, J, Hale, G, Hazleman, B, Waldmann, H
Format:	Journal article
Published:	1992

Similar Items

CAMPATH-1H in inflammatory arthritis.
by: Watts, R, et al.
Published: (1993)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
by: Isaacs, J, et al.
Published: (1992)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
by: Kyle, V, et al.
Published: (1991)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
by: Isaacs, J, et al.
Published: (1996)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
by: Isaacs, J, et al.
Published: (1992)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
by: Isaacs, J, et al.
Published: (2004)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
by: Isaacs, J, et al.
Published: (2005)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
by: Isaacs, J, et al.
Published: (2005)

THE USE OF MONOCLONAL ANTILYMPHOCYTE ANTIBODIES IN CLINICAL IMMUNOSUPPRESSION
by: Friend, P, et al.
Published: (1985)

Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: comment on the article by Isaacs et al - Reply
by: Isaacs, J, et al.
Published: (2002)

Specificity of monoclonal antibody Campath-1.
by: Hale, G, et al.
Published: (1988)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
by: Isaacs, J, et al.
Published: (1995)

Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.
by: Friend, P, et al.
Published: (1995)

A personal history of the CAMPATH-1H antibody.
by: Waldmann, H
Published: (2002)

Availability of Campath-1 antibodies for bone marrow transplantation.
by: Hale, G, et al.
Published: (1995)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
by: Hale, G, et al.
Published: (1994)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
by: Newman, D, et al.
Published: (1995)

Campath-1H therapy in refractory ocular inflammatory disease.
by: Dick, A, et al.
Published: (2000)

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.
by: Hale, G, et al.
Published: (1983)

Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
by: Hale, G, et al.
Published: (1988)

ISOTYPE VARIANTS OF CAMPATH-1 ANTIBODY - REQUIREMENTS FOR EFFECTIVE ANTIBODY ACTION INVIVO
by: Dyer, M, et al.
Published: (1989)

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
by: Hale, G, et al.
Published: (2002)

Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.
by: Kyle, V, et al.
Published: (1989)

FAILURE TO DETECT ANTILYMPHOCYTIC ANTIBODIES (ALA) IN AIDS
by: Beall, G, et al.
Published: (1987)

CAMPATH-1 antibodies in stem-cell transplantation.
by: Hale, G, et al.
Published: (2001)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
by: Hale, G, et al.
Published: (1996)

The effect of treatment with Campath-1H in patients with autoimmune cytopenias.
by: Willis, F, et al.
Published: (2001)

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.
by: Isaacs, J, et al.
Published: (2001)

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype.
by: Dyer, M, et al.
Published: (1989)

Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes.
by: Lorenzi, A, et al.
Published: (2008)

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
by: Williams, R, et al.
Published: (2000)

Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trial.
by: Friend, P, et al.
Published: (1987)

1.9 A structure of the therapeutic antibody CAMPATH-1H fab in complex with a synthetic peptide antigen.
by: James, L, et al.
Published: (1999)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
by: Lim, S, et al.
Published: (1993)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
by: Rebello, P, et al.
Published: (1999)

Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
by: Lawson, C, et al.
Published: (2005)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
by: Dyer, M, et al.
Published: (1988)

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
by: Hale, G, et al.
Published: (1986)

REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES
by: Dyer, M, et al.
Published: (1990)

CAMPATH-1 MOAB IN THE TREATMENT OF REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA (ATP)
by: Lim, S, et al.
Published: (1993)